Protection against degradation is related to the entrapment of the drug inside core of vesicle which provides protection till reaching site of absorption 27,28
The absence of a listed interaction is not the same as proof of safety, but the pharmacokinetic analysis above explains why no interaction would be expected
Topical cosmetic use and experimental injectable use are treated very differently under the law, even when the molecule is the same
It's also theoretically possible, though not documented, that the powerful angiogenic effects of BPC-157 could be a concern in subjects with pre-existing conditions where new blood vessel growth is undesirable
Patients may complete visits through secure telehealth when appropriate, with in-person consultations available at our Hollywood, FL office
Cell Reports, 27 (2), 491501